Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages

Journal of Asthma

Volumn 36, Issue 8, 1999, Pages 665-670

  Suzuki, Masashi ^a   Teramoto, Shinji ^a   Katayama, Hirofumi ^a   Ohga, Eijiro ^a   Matsuse, Takeshi ^a   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Alacepril; Chemiluminescence; Licinopril; Pulmonary alveolar macrophage; Reactive oxygen species

Indexed keywords

ALACEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LUCIGENIN; OXYGEN RADICAL; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GUINEA PIG; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 0033384813     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909909055418     Document Type: Article

References (27)

1. Cluzel M, Damon M, Chanez P, et al: Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J Allergy Clin Immunol 80:195 (1987).
2. Kanazawa H, Kurihara N, Hirata K, Takeda T: The role of free radicals in airway obstruction in asthmatic patients. Chest 100:1319 (1991).
3. Teramoto S, Chu C-Y, Ouchi Y, Fukuchi Y: Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J Asthma 33:149 (1996).
4. Repine JE, Bast A, Lankhorst I, and the Oxidative Stress Study Group: Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:341 (1997).
5. Rahman I, Morisson D, Donaldson K, MacNee W: Systemic oxidant stress in asthma, COPD and smokers. Am J Respir Crit Care Med 154:1055 (1996).
6. Strausz J, Muller-Quernheim J, Steppling H, Ferlinz R: Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 141:124 (1990).
7. Teramoto S, Fukuchi Y, Uejima Y, Chu C-Y, Orimo H: Superoxide anion formation and glutathione metabolism of blood in patients with idiopathic pulmonary fibrosis. Biochem Mol Med 55:66 (1995).
8. Ondetti MA, Rubin B, Cushman DW: Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active hypertensive agents. Science 196:441 (1977).
9. Williams GH: Converting-enzyme inhibitors in the treatment for hypertension. N Engl J Med 319:1517 (1998).
10. Kleber FX, Wensel R: Current guidelines for the treatment of congestive heart failure. Drugs 51:89 (1996).
11. Glassock RJ: The therapy of idiopathic membranous glomerulonephritis. Semin Nephrol 11:138 (1991).
12. Martin MFR, McKenna F, Bird HA, Surral KE, Dixon JS, Wright V: Captopril: A new treatment for rheumatoid arthritis? Lancet i:1325 (1988).
13. Hirawa N, Uehara Y, Kawabata Y, et al: Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitors in Dahl salt-sensitive rats. J Hypertens 12:909 (1994).
14. Mira ML, Silva MM, Queiroz MJ, Manso CF: Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic Res Commun 19:173 (1993).
15. Lapenna D, Cuccurullo F: Captopril; Does it act as a direct antioxidant by free radical scavenging in humans? Free Radic Biol Med 14:643 (1993).
16. Suzuki S, Sato H, Shimada H, Takashima N, Arakawa M: Comparative free radical scavenging action of angiotensin-converting enzyme inhibitor with and without the sulfhydryl radical. Pharmacology 47:61 (1993).
17. Bartosz M, Kedziora J, Bartosz G: Antioxidant and prooxidant properties of captopril and enalapril. Free Radic Biol Med 23:729 (1997).
18. Noda A, Mori A, Packer L: Free radical scavenging properties of alacepril metabolites and licinopril. Res Commun Mol Pathol Pharmacol 96:125 (1997).
19. Inagaki M: An increase in superoxide generation of bronchoalveolar lavage fluids in the model of late asthmatic response in guinea pig. J Asthma 30:401 (1993).
20. He L, Chang S-W, Oritiz de Montellano P, et al: Lung injury in Fischer but not Sprague-Dowley rats after short-term hyperoxia. Am J Physiol 259:L172 (1990).
21. Suzuki M, Teramoto S, Matsuse T, Ohga E, Katayama H, Fukuchi Y, Ouchi Y: Inhibitory effect of ambroxol on superoxide anion production and generation by murine alveolar macrophages. J Asthma 35: 267 (1998).
22. Teramoto S, Suzuki T, Matsuse T, Ouchi: Effect of ambroxol on oxygen radical production and generation by bronchoalveolar lavage cells in young and aged guinea pigs. Jpn J Pharmacol 78:429 (1998).
23. Teramoto S, Fukuchi Y, Shu CY, Orimo H: Influences of cisplatin combination chemotherapy on oxygen radical generation by blood in elderly and adult patients with lung cancer. Chemotherapy 41:222 (1995).
24. Teramoto S, Fukuchi Y, Uejima Y, Teramoto K, Orimo H: Biochemical characteristics of lungs in senescence-accelerated mouse (SAM). Eur Respir J 8:450 (1995).
25. Ward WF, Molteni A, Ts'ao CH, Hinz JM: Captopril reduces colaged and mast cell accumulation in irradiated rat lung. Int J Radiat Oncol Biol Phys 19:1405 (1990).
26. Ward WF, Lin PJ, Wong PS, Behnia R, Jalali N: Radiation pneumonitis in rats and its modification by the angiotensin-converting enzyme inhibitor captopril evaluated by high-resolution computed tomography. Radiat Res 235:81 (1993).
27. Calhoun WJ, Stevens CA, Lambert SB: Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 117:514 (1991).